Dauntless Investment Group’s Novavax NVAX Stock Holding History

Dauntless Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-86,861	Closed	-$698K	–	74
2024 Q4	$698K	Buy	+86,861	New	+$837K	0.73%	18

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dauntless Investment Group's NVAX Position: Q1 2025 in Review

Dauntless Investment Group sold out of Novavax (NVAX) in Q1 2025, closing a stake of 86,861 shares — an estimated $698K sold.

Dauntless Investment Group first reported a position in NVAX in Q4 2024 and held it in 1 quarter. The position peaked at $698K in Q4 2024. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

Dauntless Investment Group reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
Dauntless Investment Group sold 86,861 Novavax shares in Q1 2025, an estimated $698K.
Dauntless Investment Group first reported a position in Novavax in Q4 2024 and held it in 1 quarter.
Dauntless Investment Group's Novavax position peaked at $698K in Q4 2024.
245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Dauntless Investment Group's 13F filing for Q1 2025, filed 7 May 2025.